Company intelligence / Profile preview

Rosetta Life Care

Mumbai, Maharashtra, Indiarosettalifecare.com ↗
Ownership
Private
Development stage
Other
01

Overview

Rosetta Life Care markets finished pharmaceutical and nutraceutical formulations in Asia and the Middle East, as well as proprietary food supplements in Europe. Their peptide-based product EnzoImmune Max is marketed for immune support and claims scientific proof of antiviral efficacy; however, there is no evidence of clinical trial results in the public domain.

Therapeutic areas
CardiovascularImmunologyEndocrinologyInfectious DiseasesNeurology
Modalities
BiologicPeptidesSmall moleculeNutraceutical
Industry
Biotech
02

Drug pipeline

5 assets

ROVICAL-D Strong

Unknown

4 more assets in the full pipeline.

Beyond the preview

Go deeper on Rosetta Life Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rosetta Life Care.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call